RARA CRAFT DATABASE for FDA Medical Devices

FDA Guidance Navigator

FDA Guidance Navigator

Clinical evaluation

Searching the text of the documents is available for 7 days after free registration and on the paid plan. Create a free account
69 documents (loading the full list)
  1. Federal Register publication date

    Agency Information Collection Activities; Proposed Collection; Comment Request; Protection of Human Subjects and Institutional Review Boards

    NoticeClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  2. Federal Register publication date

    Statistical Considerations for the Design of Rare Disease Clinical Investigations; Establishment of a Public Docket; Request for Information and Comments

    NoticeClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  3. Unknown
  4. Unknown
  5. Unknown

    Institutional Review Boards Frequently Asked Questions: Guidance for Institutional Review Boards and Clinical Investigators

    Information sheetFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  6. Unknown
  7. Unknown
  8. Unknown

    Use of Data Monitoring Committees in Clinical Trials

    GuidanceDraftClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  9. Unknown

    Considerations for the Conduct of Clinical Trials of Medical Products During Major Disruptions Due to Disasters and Public Health Emergencies

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  10. Unknown

    Informed Consent: Guidance for IRBs, Clinical Investigators, and Sponsors

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  11. Unknown

    A Risk-Based Approach to Monitoring of Clinical Investigations Questions and Answers: Guidance for Industry

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  12. Unknown

    Clinical Investigator Administrative Actions - Disqualification: Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  13. Unknown

    Clinical Performance Assessment: Considerations for Computer-Assisted Detection Devices Applied to Radiology Images and Radiology Device Data in Premarket Notification (510(k)) Submissions: Guidance for Industry and FDA Staff

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  14. Unknown

    Ethical Considerations for Clinical Investigations of Medical Products Involving Children: Draft Guidance for Industry, Sponsors, and IRBs

    GuidanceDraftClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  15. Unknown

    Inclusion of Older Adults in Cancer Clinical Trials: Guidance for Industry

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  16. Unknown

    Civil Money Penalties Relating to the ClinicalTrials.gov Data Bank: Guidance for Responsible Parties, Submitters of Certain Applications and Submissions to FDA, and FDA Staff

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  17. Unknown

    Impact of Certain Provisions of the Revised Common Rule on FDA-Regulated Clinical Investigations: Guidance for Sponsors, Investigators, and Institutional Review Boards

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  18. Unknown

    Use of Electronic Health Record Data in Clinical Investigations Guidance for Industry

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  19. Unknown

    Payment and Reimbursement to Research Subjects: Guidance for Institutional Review Boards and Clinical Investigators

    Information sheetFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  20. Unknown

    Minutes of Institutional Review Board (IRB) Meetings: Guidance for Institutions and IRBs

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  21. Unknown

    Use of Electronic Informed Consent in Clinical Investigations – Questions and Answers: Guidance for Institutional Review Boards, Investigators, and Sponsors

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  22. Unknown

    Considerations When Transferring Clinical Investigation Oversight to Another IRB: Guidance for IRBs, Clinical Investigators, and Sponsors

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  23. Unknown

    Design Considerations for Pivotal Clinical Investigations for Medical Devices: Guidance for Industry, Clinical Investigators, Institutional Review Boards and FDA Staff

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  24. Unknown

    Electronic Source Data in Clinical Investigations: Guidance for Industry

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  25. Unknown

    IRB Responsibilities for Reviewing the Qualifications of Investigators, Adequacy of Research Sites, and the Determination of Whether an IND/IDE is Needed: Guidance for IRBs, Clinical Investigators, and Sponsors

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  26. Unknown

    Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring: Guidance for Industry

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  27. Unknown

    Exception from Informed Consent Requirements for Emergency Research: Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  28. Unknown

    Investigational Device Exemption (IDE) Guidance for Retinal Prostheses: Guidance for Industry and FDA Staff

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  29. Unknown

    Financial Disclosure by Clinical Investigators: Guidance for Clinical Investigators, Industry,and FDA Staff

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  30. Unknown

    IRB Continuing Review After Clinical Investigation Approval: Guidance for IRBs, Clinical Investigators, and Sponsors

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  31. Unknown

    Questions and Answers on Informed Consent Elements, 21 CFR § 50.25(c): Guidance for Sponsors, Investigators, and Institutional Review Boards

    Small Entity Compliance GuideFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  32. Unknown

    Exculpatory Language in Informed Consent

    GuidanceDraftClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  33. Unknown

    Clinical Investigations of Devices Indicated for the Treatment of Urinary Incontinence - Guidance for Industry and FDA Staff

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  34. Unknown

    Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials (PDF Version)

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  35. Unknown

    Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  36. Unknown

    Frequently Asked Questions - IRB Registration: Guidance for Institutional Review Boards (IRBs)

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  37. Unknown

    Data Retention When Subjects Withdraw from FDA-Regulated Clinical Trials: Guidance for Sponsors, Clinical Investigators, and IRBs

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  38. Unknown

    Clinical Study Designs for Catheter Ablation Devices for Treatment of Atrial Flutter: Guidance for Industry and FDA Staff

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  39. Unknown

    Investigational Device Exemptions (IDEs) for Devices Indicated for Nocturnal Home Hemodialysis: Guidance for Industry and FDA Staff

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  40. Unknown

    Preparation and Review of Investigational Device Exemption Applications (IDEs) for Total Artificial Discs: Guidance for Industry and FDA Staff

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  41. Unknown

    Non-clinical Information for Femoral Stem Prostheses: Guidance for Industry and FDA Staff

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  42. Unknown

    Process for Handling Referrals to FDA Under 21 CFR 50.54 - Additional Safeguards for Children in Clinical Investigations: Guidance for Clinical Investigators, Institutional Review Boards and Sponsors

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  43. Unknown

    Establishment and Operation of Clinical Trial Data Monitoring Committees: Guidance for Clinical Trial Sponsors

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  44. Unknown

    Frequently Asked Questions About Medical Devices: Guidance For IRBs, Clinical Investigators, and Sponsors

    Information sheetFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  45. Unknown

    Clinical Data Presentations for Orthopedic Device Applications - Guidance for Industry and FDA Staff

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  46. Unknown

    Clinical Trial Considerations: Vertebral Augmentation Devices to Treat Spinal Insufficiency Fractures - Guidance for Industry and FDA Staff

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  47. Unknown

    The Use of Clinical Holds Following Clinical Investigator Misconduct: Guidance for Industry and Clinical Investigators

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  48. Unknown

    Changes or Modifications During the Conduct of a Clinical Investigation; Final Guidance for Industry and CDRH Staff

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  49. Unknown

    Content of Investigational Device Exemptions for Solutions for Hypothermic Flushing, Transport and Storage of Organs for Transplantation - Guidance for Industry and FDA Reviewers

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

  50. Unknown

    Recommended Clinical Study Design for Ventricular Tachycardia Ablation

    GuidanceFinalClinical evaluationMembers

    Details and links of this resource are for members. Start free 7-day access · Log in

RA Craft Database is an independent service, not affiliated with the U.S. FDA. The FDA originals are the authoritative source.